Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Ultragenyx Analyst Day Presentation slide image

Ultragenyx Analyst Day Presentation

MEPSEVII® Exclusivity summary 24 United States MPS7 Orphan Exclusivity Biologics Exclusivity 2024 2029 Mepsevii (vestronidase alfa-vjbk) injection, for intravenous use 10 mg/5 mL (2 mg/mL) Mepsevii COM Patent 2035 2018 2020 2022 2024 2026 2028 2030 2032 2034 2036 Europe Confidential and Proprietary 2028 MPS7 Orphan + D&M Exclusivity 2035 Mepsevii COM Patent ultragenyx
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube